Pasithea Therapeutics Cor... (KTTA)
NASDAQ: KTTA
· Real-Time Price · USD
0.79
0.00 (0.13%)
At close: Oct 03, 2025, 3:30 PM
0.78
-0.81%
After-hours: Oct 03, 2025, 07:55 PM EDT
Pasithea Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -13.46M | -13.61M | -13.9M | -15.76M | -16.37M | -16.1M | -15.51M | -15.59M | -16.17M | -15.23M | -13.54M | -7.79M | -5.13M | -3.2M | -2.17M | -2.8M | -1.28M | -549.61K |
Depreciation & Amortization | 647.97K | 648.48K | 649.03K | 648.99K | 648.99K | 648.99K | 648.45K | 486.23K | 323.98K | 172.51K | 15.8K | 17.18K | 17.18K | 6.39K | 1.38K | n/a | n/a | n/a |
Stock-Based Compensation | 422.47K | 525.77K | 773.69K | 725.25K | 704.04K | 761.73K | 592.27K | 678.5K | 535.76K | 876.46K | 835.06K | 835.48K | 866.54K | 307.21K | 171.59K | 15K | n/a | n/a |
Other Working Capital | 1.41M | 1.26M | n/a | -522.44K | 108.47K | 954.96K | 35.75M | -796.31M | -797.6M | -797.78M | -831.93M | -1.67M | -516.22K | -649.17K | -354.18K | n/a | n/a | n/a |
Other Non-Cash Items | -3.05B | -3.05B | -770.58K | 1.18M | 1.11M | 1.08M | 479.66K | -433.04K | 975.56K | 552.9K | -280.22K | 170.05K | 77.86K | 516.37K | 1.3M | 1.33M | 16.8K | n/a |
Deferred Income Tax | n/a | n/a | n/a | -394.38K | 143.75K | -434.41K | -434.41K | -40.03K | -578.16K | n/a | n/a | -2.59M | -2.59M | -2.59M | -2.59M | n/a | n/a | n/a |
Change in Working Capital | 1.41M | 1.26M | n/a | -522.44K | 108.47K | 954.96K | 1.57M | 1.15M | 267.91K | 85.82K | 100.27K | -838.94K | -443.87K | -365.12K | 111.23K | 24.74K | 379.47K | 167.76K |
Operating Cash Flow | -3.07B | -3.07B | -13.92M | -14.79M | -14.33M | -13.77M | -12.65M | -13.76M | -15.32M | -14.22M | -13.54M | -10.87M | -7.2M | -5.32M | -3.17M | -1.43M | -881.28K | -381.85K |
Capital Expenditures | n/a | n/a | n/a | n/a | 22.66K | 19.55K | -34.34K | -1.82M | -1.85M | -1.89M | -1.95M | -170.6K | -165.11K | -126.8K | -12.93K | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | 54.5K | 82K | 109.5K | 109.5K | 87.98K | 40K | 89.56K | 89.56K | 56.58K | 77.06K | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | 54.5K | 82K | 401.62K | 397.43K | 1.44M | 227.37K | -631.09K | -626.9K | -1.73M | -538.84K | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | 54.54K | 104.69K | 448.7K | 394.82K | -1.42M | -1.65M | -1.96M | -2.02M | -273.97K | -96.62K | -135.37K | -21.5K | -8.57K | n/a | n/a |
Debt Repayment | -292.82K | -179.31K | n/a | n/a | -133.34K | -133.34K | -133.34K | -133.34K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | -3.72B | -3.73B | -3.73B | -3.73B | -3.73M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -719.31M | -719.31M | -719.31M | -359.66M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 720.59M | 719.31M | 719.31M | 359.66M | n/a | -130.77K | 133.34K | -3.07M | -4.1M | -3.86M | -4.13M | 6.08M | 5.8M | 5.69M | 5.69M | -1.31M | 390.51 | 390.51 |
Financial Cash Flow | 11.73M | 5.99M | 4.52M | 4.52M | -4.47M | -4.6M | -4.34M | -7.53M | -4.1M | -3.86M | -4.13M | 33.25M | 54.83M | 54.72M | 55.93M | 21.76M | 1.21M | 1.21M |
Net Cash Flow | -1.58B | -1.59B | -9.41M | -10.22M | -18.68M | -17.9M | -16.76M | -22.75M | -21.21M | -20.32M | -19.79M | 21.86M | 47.37M | 49.25M | 52.72M | 20.32M | 325.33K | 827.08K |
Free Cash Flow | -3.07B | -3.07B | -13.92M | -14.79M | -14.3M | -13.75M | -12.68M | -15.58M | -17.17M | -16.11M | -15.49M | -11.04M | -7.36M | -5.45M | -3.19M | -1.43M | -881.28K | -381.85K |